NCT02271009
Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC No drug interventions treatment 2 completed NCT03758456
HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human No drug interventions treatment 1 completed NCT04071249
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis No drug interventions Not Available Not Available completed NCT05668390
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma No drug interventions treatment 3 active_not_recruiting NCT01740284
A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine treatment 3 completed NCT01489033
Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense No drug interventions treatment 1 completed NCT02131051
Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis No drug interventions Not Available Not Available completed NCT02488447
Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis No drug interventions Not Available Not Available completed NCT01490411
Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis No drug interventions treatment 2 completed NCT05400811
Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis No drug interventions treatment 3 not_yet_recruiting NCT00841256
Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children treatment 3 completed NCT01918956
PURETHAL Birch RUSH Study No drug interventions treatment 4 completed NCT06448585
Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. No drug interventions treatment 4 active_not_recruiting NCT00550875
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis No drug interventions treatment 2 completed NCT01682070
SUBLIVAC FIX Phleum Pratense DT/DRF No drug interventions treatment 2 completed NCT00411606
Normal Values of Facial Thermography No drug interventions Not Available Not Available completed NCT05455749
Effect of holoBLG on Cat Allergic Patients No drug interventions treatment Not Available completed NCT01535118
A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) No drug interventions Not Available Not Available completed NCT01564017
Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract No drug interventions treatment 2 completed NCT00841516
Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative No drug interventions basic_science 2 completed NCT00985296
Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC) No drug interventions Not Available Not Available completed NCT02069535
An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy No drug interventions treatment 2 completed NCT04898686
Probiotic Chewables in Allergic Rhinoconjunctivitis Patients treatment Not Available completed NCT02437786
Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX® No drug interventions other 4 completed NCT03365648
Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics No drug interventions treatment Not Available completed NCT01085526
Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis No drug interventions basic_science Not Available completed NCT03850626
Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients No drug interventions Not Available Not Available completed NCT00777374
Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration No drug interventions treatment 2 completed NCT01454531
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy No drug interventions treatment 2 / 3 completed NCT01438827
Avanz Phleum Pratense Maintenance Dose No drug interventions treatment 2 / 3 completed NCT04532762
Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray. No drug interventions treatment Not Available completed NCT02556801
Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy No drug interventions treatment 2 completed NCT05641272
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract No drug interventions prevention 2 / 3 not_yet_recruiting NCT01639768
SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding No drug interventions treatment 2 completed NCT01433510
Tolerability of Grazax in Patients With Hayfever in Real Life Settings No drug interventions treatment 4 completed NCT04874714
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis No drug interventions treatment 3 terminated NCT02297490
Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials No drug interventions basic_science 2 terminated NCT02881879
Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites No drug interventions treatment 1 completed NCT00973453
Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients No drug interventions Not Available 2 completed NCT00824447
Long-term Efficacy and Safety Study With Oralgen Grass Pollen No drug interventions treatment 2 / 3 completed NCT02506998
Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts No drug interventions treatment 2 completed NCT02481856
A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber No drug interventions treatment 2 completed NCT04176185
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber treatment 3 terminated NCT02394600
The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation treatment 4 completed NCT00985075
A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube No drug interventions Not Available Not Available completed NCT00812799
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis No drug interventions treatment 3 unknown_status NCT01567306
Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense No drug interventions treatment 2 completed NCT01966224
A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects No drug interventions treatment 1 completed NCT04531358
Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis No drug interventions treatment Not Available completed NCT01438463
PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis No drug interventions treatment 2 completed NCT01852825
MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) No drug interventions diagnostic 1 completed NCT03887026
Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis No drug interventions treatment 2 completed NCT01059266
PURETHAL Grasses Rush Study No drug interventions treatment 4 completed NCT04502966
Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction treatment 2 active_not_recruiting NCT01466465
Vitamin D and Grass Pollen Specific Immunotherapy treatment 2 completed NCT03682965
Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study No drug interventions treatment 2 completed NCT01081574
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) treatment 1 / 2 completed NCT01489020
Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT) No drug interventions treatment 1 completed NCT05192720
Andosan in Allergic and Asthma Patients No drug interventions other Not Available completed NCT04912076
S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen No drug interventions treatment 1 completed NCT00916760
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica treatment 3 completed NCT01902992
Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch No drug interventions treatment 3 completed NCT04541004
Adolescent Mite Allergy Safety Evaluation treatment 3 completed NCT02159404
Nasal Mucus Proteome and Immunotherapy No drug interventions Not Available Not Available recruiting NCT01707069
A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid No drug interventions treatment 1 completed NCT00567346
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy No drug interventions treatment 2 / 3 completed